Related references
Note: Only part of the references are listed.Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review
Kyoko Oura et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Diagnostic value of fibrinogen to prealbumin ratio and gamma-glutamyl transpeptidase to platelet ratio in the progression of AFP-negative hepatocellular carcinoma
Li Huang et al.
CANCER CELL INTERNATIONAL (2020)
Challenges and Strategies in Ascribing Functions to Long Noncoding RNAs
Yang Zhao et al.
CANCERS (2020)
Principles and innovative technologies for decrypting noncoding RNAs: from discovery and functional prediction to clinical application
Yu-Meng Sun et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Non-coding RNAs, metabolic stress and adaptive mechanisms in cancer
Xiaoying Liu et al.
CANCER LETTERS (2020)
Chinese guidelines on the management of liver cirrhosis (abbreviated version)
Xiao-Yuan Xu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
The Diagnostic Value of Serum ST8SIA6-AS1 as Biomarker in Hepatocellular Carcinoma
S. J. Qin et al.
CLINICAL LABORATORY (2020)
The functional role of long noncoding RNA in resistance to anticancer treatment
Yidi Qu et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Plasmacytoid pre-dendritic cells (pDC): from molecular pathways to function and disease association
Solana Alculumbre et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2019)
Baishouwu Extract Suppresses the Development of Hepatocellular Carcinoma via TLR4/MyD88/NF-κB Pathway
Yong-fang Ding et al.
FRONTIERS IN PHARMACOLOGY (2019)
Evaluation of serum long noncoding RNA NEAT and MiR-129-5p in hepatocellular carcinoma
Olfat G. Shaker et al.
IUBMB LIFE (2019)
The expression level and clinical significance of lncRNA X91348 in hepatocellular carcinoma
Zhen Zeng et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
lncRNA-D16366 Is a Potential Biomarker for Diagnosis and Prognosis of Hepatocellular Carcinoma
Yanjun Chao et al.
MEDICAL SCIENCE MONITOR (2019)
The Role of Non-coding RNAs in Oncology
Frank J. Slack et al.
CELL (2019)
Serum milk fat globule-EGF factor 8 (MFG-E8) as a diagnostic and prognostic biomarker in patients with hepatocellular carcinoma
Tomonari Shimagaki et al.
SCIENTIFIC REPORTS (2019)
Low expression of long noncoding RNA CTC-297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma
Sicong Zhu et al.
CANCER MEDICINE (2019)
Opposing roles of eosinophils in cancer
Sonja C. S. Simon et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Current Cancer Epidemiology
Camilla Mattiuzzi et al.
JOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH (2019)
Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression
Yajia Zhang et al.
NATURE GENETICS (2018)
Regulator of calcineurin 1 differentially regulates TLR-dependent MyD88 and TRIF signaling pathways
Zheng Pang et al.
PLOS ONE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
The clinical management of hepatocellular carcinoma worldwide: A concise review and comparison of current guidelines from 2001 to 2017
Peipei Song et al.
BIOSCIENCE TRENDS (2017)
Long non-coding RNA Myd88 promotes growth and metastasis in hepatocellular carcinoma via regulating Myd88 expression through H3K27 modification
Xiaoliang Xu et al.
CELL DEATH & DISEASE (2017)
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015
Tomi Akinyemiju et al.
JAMA ONCOLOGY (2017)
Extracellular vesicle long noncoding RNA as potential biomarkers of liver cancer
Swathi Mohankumar et al.
BRIEFINGS IN FUNCTIONAL GENOMICS (2016)
miR-489 inhibits silica-induced pulmonary fibrosis by targeting MyD88 and Smad3 and is negatively regulated by lncRNA CHRF
Qiuyun Wu et al.
SCIENTIFIC REPORTS (2016)
Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection
Thomas G. Bird et al.
PLOS ONE (2016)
Epidemiology and Survival of Hepatocellular Carcinoma in the Central Region of Thailand
Krittapong Somboon et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Decrypting Cryptogenic Hepatocellular Carcinoma: Clinical Manifestations, Prognostic Factors and Long-Term Survival by Propensity Score Model
Chia-Yang Hsu et al.
PLOS ONE (2014)
Prevalence and Clinical Relevance of T-Helper Cells, Th17 and Th1, in Hepatitis B Virus-Related Hepatocellular Carcinoma
Jian Yan et al.
PLOS ONE (2014)
Diagnostic value of glypican-3 in alpha fetoprotein negative hepatocellular carcinoma patients
B. Li et al.
AFRICAN HEALTH SCIENCES (2013)
Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression
Kai-hua Lu et al.
BMC CANCER (2013)
The role of signaling pathways in the development and treatment of hepatocellular carcinoma
S. Whittaker et al.
ONCOGENE (2010)
Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009
Donald Poon et al.
LANCET ONCOLOGY (2009)
Share Paper
